These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 8164599)

  • 1. [The effectiveness of ranitidine in non-ulcer dyspepsia (functional dyspepsia) in comparison with an antacid].
    Hotz J; Plein K; Bunke R
    Med Klin (Munich); 1994 Feb; 89(2):73-80, 107. PubMed ID: 8164599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
    Carvalhinhos A; Fidalgo P; Freire A; Matos L
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranitidine in the treatment of non-ulcer dyspepsia. A placebo-controlled study in the Federal Republic of Germany.
    Müller P; Hotz J; Franz E; Simon B
    Arzneimittelforschung; 1994 Oct; 44(10):1130-2. PubMed ID: 7818586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of stomach ulcer--a comparison between the low dosage antacid hydrotalcite and ranitidine--results of a randomized multicenter double-blind study. Talcivent Study Group].
    Holtermüller KH; Liszkay M; Bernard I; Haase W
    Z Gastroenterol; 1992 Oct; 30(10):717-21. PubMed ID: 1441674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antacid therapy of upper abdominal symptoms. Double-blind study on the effect and tolerance of 2 antacids in gastritis , esophagitis and functional upper abdominal symptoms].
    Lichtenstein H
    Fortschr Med; 1991 Sep; 109(26):528-32. PubMed ID: 1783346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Using gaviscon preparation for relief of esophageal, extraesophageal syndromes and functional dyspepsia in elderly patients with GERD].
    Onuchina EV; Brikova SI; Tsukanov VV
    Eksp Klin Gastroenterol; 2010; (10):80-6. PubMed ID: 21434379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ranitidine therapeutically effective in functional dyspepsia with reflux-like symptoms].
    Jebbink HJ; Smout AJ; van Berge Henegouwen GP
    Ned Tijdschr Geneeskd; 1993 Aug; 137(35):1772-5. PubMed ID: 8371822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of itopride hydrochloride and ranitidine in patients with functional dyspepsia: comparison between prokinetic and acid suppression therapies.
    Chiba T; Tokunaga Y; Ikeda K; Takagi R; Chishima R; Terui T; Kudara N; Endo M; Inomata M; Orii S; Suzuki K
    Hepatogastroenterology; 2007 Sep; 54(78):1878-81. PubMed ID: 18019739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of peroral antacid treatment in patients with acute upper gastrointestinal haemorrhage: a randomized controlled trial.
    Kittang E; Aadland E; Oyen D; Holm HA; Berstad A; Pytte R; Qvigstad T; Tommelstad T
    Scand J Gastroenterol Suppl; 1982; 75():109-12. PubMed ID: 6755651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranitidine and high-dose antacid in reflux oesophagitis. A randomized, placebo-controlled trial.
    Grove O; Bekker C; Jeppe-Hansen MG; Karstoft E; Sanchez G; Axelsson CK; Nielsen HO; Andersen B; Rask-Madsen J
    Scand J Gastroenterol; 1985 May; 20(4):457-61. PubMed ID: 3895381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High-dose omeprazole versus famotidine, pirenzepine and antacid in therapy of acute upper gastrointestinal hemorrhage in a retrospective comparison].
    Busam J; Garbe WE
    Z Gastroenterol; 1994 Feb; 32(2):94-9. PubMed ID: 8165833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected].
    Mason I; Millar LJ; Sheikh RR; Evans WM; Todd PL; Turbitt ML; Taylor MD
    Aliment Pharmacol Ther; 1998 Mar; 12(3):263-71. PubMed ID: 9570261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisapride, metoclopramide, and ranitidine in the treatment of severe nonulcer dyspepsia.
    Archimandritis A; Tzivras M; Fertakis A; Emmanuel A; Laoudi F; Kalantzis N; Anthopoulou H; Michailidis D
    Clin Ther; 1992; 14(4):553-61. PubMed ID: 1525789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emergency department treatment of dyspepsia with antacids and oral lidocaine.
    Welling LR; Watson WA
    Ann Emerg Med; 1990 Jul; 19(7):785-8. PubMed ID: 2202240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized clinical trial: a double-blind, placebo-controlled study to assess the clinical efficacy and safety of alginate-antacid (Gaviscon Double Action) chewable tablets in patients with gastro-oesophageal reflux disease.
    Wilkinson J; Wade A; Thomas SJ; Jenner B; Hodgkinson V; Coyle C
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):86-93. PubMed ID: 30272584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravir.
    Krishna R; East L; Larson P; Valiathan C; Butterfield K; Teng Y; Hernandez-Illas M
    J Pharm Pharmacol; 2016 Nov; 68(11):1359-1365. PubMed ID: 27671833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of ranitidine effervescent tablets and magnesium hydroxide-aluminium oxide on intragastric acidity. A single-centre, randomised, open cross-over study.
    Propst A; Propst T; Judmaier G
    Arzneimittelforschung; 1996 Jun; 46(6):621-4. PubMed ID: 8767354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sulglicotide in non-ulcerous dyspepsia].
    Bassi O; Manurita L; Morini S; Psilogenis M
    Clin Ter; 1989 Jun; 129(5):375-9. PubMed ID: 2527669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms.
    Coyle C; Crawford G; Wilkinson J; Thomas SJ; Bytzer P
    Aliment Pharmacol Ther; 2017 Jun; 45(12):1524-1533. PubMed ID: 28464343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.